✦ LIBER ✦
The mTOR-targeting drug temsirolimus enhances the growth-inhibiting effects of the cetuximab–bevacizumab–irradiation combination on head and neck cancer xenografts
✍ Scribed by Alexandre Bozec; Marie-Christine Etienne-Grimaldi; Jean-Louis Fischel; Anne Sudaka; Nicolas Toussan; Patricia Formento; Gérard Milano
- Book ID
- 113833483
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 297 KB
- Volume
- 47
- Category
- Article
- ISSN
- 1368-8375
No coin nor oath required. For personal study only.